Pressure Builds On England’s HTA Body & Industry To Reduce Data Redaction
Executive Summary
The practice of redacting data from documents submitted to NICE for health technology appraisals undermines the HTA body’s role in protecting patients’ health, says the author of a study of data redaction at NICE. But the institute counters that it would not be able to publish its recommendations as quickly if confidential information could not be removed from published documents.
You may also be interested in...
Capacity Challenges Prompt NICE To Consider Secondees From Consultancy Firms
England’s health technology assessment institute is exploring solutions to help deal with its increased workload, high staff turnover and challenges in recruiting people with the expertise needed.
UK Industry Attacks Government’s ‘Unsustainable’ Repayment Proposals
Questions are being raised about the credibility of the UK’s voluntary and statutory drug pricing schemes because of uncertainty over the payment percentages companies will have to pay in future.
2021: A Record-Breaking Year For ‘Smart’ Pricing And Access Deals In England
NHS England and Improvement (NHSE&I) agreed 16 pricing and access deals with drug companies in 2021, ten of which can be considered ‘smart.’ The fact that these were achieved against a backdrop of COVID-19 is seen as impressive.